BioCentury
ARTICLE | Clinical News

NOxCureCF: Phase II started

January 20, 2014 8:00 AM UTC

Advanced Inhalation Therapies began an open-label, Israeli Phase II trial to evaluate NOxCureCF in CF patients ages >=10 years. ...